000 | 02199 a2200601 4500 | ||
---|---|---|---|
005 | 20250516070426.0 | ||
264 | 0 | _c20120530 | |
008 | 201205s 0 0 eng d | ||
022 | _a1791-2431 | ||
024 | 7 |
_a10.3892/or.2011.1580 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTang, Bo | |
245 | 0 | 0 |
_aAlpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium. _h[electronic resource] |
260 |
_bOncology reports _cApr 2012 |
||
300 |
_a1090-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xenzymology |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCisplatin _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aEnzyme Activators _xpharmacology |
650 | 0 | 4 |
_aFlavanones _xpharmacology |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 | _aHep G2 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Neoplasms _xenzymology |
650 | 0 | 4 |
_aMAP Kinase Kinase 7 _xantagonists & inhibitors |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aResting Phase, Cell Cycle _xdrug effects |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aDu, Jian | |
700 | 1 | _aWang, Jingwen | |
700 | 1 | _aTan, Guang | |
700 | 1 | _aGao, Zhenming | |
700 | 1 | _aWang, Zhongyu | |
700 | 1 | _aWang, Liming | |
773 | 0 |
_tOncology reports _gvol. 27 _gno. 4 _gp. 1090-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3892/or.2011.1580 _zAvailable from publisher's website |
999 |
_c21382708 _d21382708 |